James A. Bianco

697 total citations
26 papers, 573 citations indexed

About

James A. Bianco is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, James A. Bianco has authored 26 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in James A. Bianco's work include Immune Response and Inflammation (5 papers), Oral health in cancer treatment (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). James A. Bianco is often cited by papers focused on Immune Response and Inflammation (5 papers), Oral health in cancer treatment (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). James A. Bianco collaborates with scholars based in United States. James A. Bianco's co-authors include Jack W. Singer, Glenn C. Rice, Stuart L. Bursten, R. J. Nelson, Paul A. Brown, Frederick R. Appelbaum, George B. McDonald, Reitha S. Weeks, Celestia S. Higano and Ernest E. Moore and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The American Journal of Medicine.

In The Last Decade

James A. Bianco

26 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Bianco United States 15 142 138 135 125 113 26 573
K. Sølling Denmark 17 103 0.7× 111 0.8× 221 1.6× 70 0.6× 82 0.7× 33 827
Rafael Perini Canada 11 103 0.7× 143 1.0× 89 0.7× 205 1.6× 144 1.3× 19 625
Yasushi Ozeki Japan 13 99 0.7× 113 0.8× 276 2.0× 153 1.2× 236 2.1× 21 892
G St-Louis Canada 16 133 0.9× 117 0.8× 124 0.9× 96 0.8× 50 0.4× 30 664
Zahit Bolaman Türkiye 15 142 1.0× 99 0.7× 123 0.9× 176 1.4× 203 1.8× 63 803
Karin Müller Germany 18 91 0.6× 88 0.6× 149 1.1× 230 1.8× 77 0.7× 59 1.0k
J Trowell United Kingdom 14 63 0.4× 87 0.6× 95 0.7× 68 0.5× 107 0.9× 22 651
F Delbarre France 16 69 0.5× 72 0.5× 162 1.2× 199 1.6× 83 0.7× 177 958
G. Ehninger Germany 15 170 1.2× 56 0.4× 162 1.2× 69 0.6× 463 4.1× 56 859
Evangelos Messaris United States 15 249 1.8× 107 0.8× 261 1.9× 250 2.0× 81 0.7× 36 875

Countries citing papers authored by James A. Bianco

Since Specialization
Citations

This map shows the geographic impact of James A. Bianco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Bianco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Bianco more than expected).

Fields of papers citing papers by James A. Bianco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Bianco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Bianco. The network helps show where James A. Bianco may publish in the future.

Co-authorship network of co-authors of James A. Bianco

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Bianco. A scholar is included among the top collaborators of James A. Bianco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Bianco. James A. Bianco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sher, David J., Marcelo Bonomi, Dukagjin Blakaj, et al.. (2020). Results of a Randomized, Open Label, Multicenter Trial Assessing the Safety, Dose and Schedule of RRx-001 (R001) in Reducing Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiation (CRT) for Oral Cavity/oropharynx Squamous Cell Carcinoma (OSCC). International Journal of Radiation Oncology*Biology*Physics. 108(3). S107–S108. 3 indexed citations
3.
Bursten, Stuart L., Polly E. Parsons, Ward E. Harris, et al.. (1996). An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome. Critical Care Medicine. 24(7). 1129–1136. 70 indexed citations
4.
Russell, Kenneth, Linda Wiens, G W Demers, et al.. (1996). Preferential radiosensitization of G1 checkpoint—Deficient cells by methylxanthines. International Journal of Radiation Oncology*Biology*Physics. 36(5). 1099–1106. 42 indexed citations
5.
Rice, Glenn C., et al.. (1994). CT-1501R SELECTIVELY INHIBITS INDUCED INFLAMMATORY MONOKINES IN HUMAN WHOLE BLOOD EX VIVO. Shock. 1(4). 254–266. 41 indexed citations
6.
Thompson, John A., James A. Bianco, Mark Benyunes, et al.. (1994). Phase Ib trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma.. PubMed. 54(13). 3436–41. 22 indexed citations
7.
Teefey, Sharlene A., et al.. (1994). Gallbladder sludge formation after bone marrow transplant: Sonographic observations. Abdominal Imaging. 19(1). 57–60. 22 indexed citations
8.
Singer, Jack W., et al.. (1994). Inhibitors of intracellular phosphatidic acid production: novel therapeutics with broad clinical applications. Expert Opinion on Investigational Drugs. 3(6). 631–644. 16 indexed citations
10.
Thompson, John A., Catherine Lindgren, Mark Benyunes, et al.. (1993). The Effects of Pentoxifylline on the Generation of Human Lymphokine-Activated Killer Cell Cytotoxicity. Journal of Immunotherapy. 13(2). 84–90. 4 indexed citations
11.
Singer, Jack W., CD Buckner, R Clift, et al.. (1992). Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma.. Journal of Clinical Oncology. 10(9). 1492–1497. 45 indexed citations
12.
Singer, Jack W., et al.. (1992). Toxic Epidermal Necrolysis Possibly Linked to Aztreonam in Bone Marrow Transplant Patients. Annals of Pharmacotherapy. 26(1). 34–35. 16 indexed citations
14.
Sandmaier, Brenda M., Friedrich Schuening, James A. Bianco, et al.. (1991). Biochemical characterization of a unique canine myeloid antigen.. PubMed. 5(2). 125–30. 22 indexed citations
16.
Bianco, James A., Margaret S. Pepe, Celestia S. Higano, et al.. (1990). Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients. The American Journal of Medicine. 89(2). 134–136. 34 indexed citations
17.
Bianco, James A. & Frederick R. Appelbaum. (1990). Biotherapy after marrow transplantation and the use of hematopoietic growth factors. Current Opinion in Oncology. 2(2). 289–296. 2 indexed citations
18.
Bianco, James A., Paul A. Brown, Christopher C. Badger, et al.. (1990). Effects of propylthiouracil on the biodistribution of an iodine-131-labeled anti-myeloid antibody in normal dogs: dosimetry and clinical implications.. PubMed. 31(8). 1384–9. 1 indexed citations
19.
Bianco, James A., et al.. (1987). Radionuclide Ventriculography in Normal Volunteers Performing Graded Supine Bicycle Exercise. American Journal of Noninvasive Cardiology. 1(1). 56–60. 1 indexed citations
20.
Bianco, James A., et al.. (1984). Efficacy of 67 gallium ECT imaging in lymphoma, infection, and lung carcinoma: A comparison with planar imaging. 25(5). 44. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026